Dermisonics, Inc. (DMSI)
DMSI Stock Price Chart
Explore Dermisonics, Inc. interactive price chart. Choose custom timeframes to analyze DMSI price movements and trends.
DMSI Company Profile
Discover essential business fundamentals and corporate details for Dermisonics, Inc. (DMSI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Specialties
IPO Date
11 Jul 2003
Employees
—
CEO
Bruce H. Haglund
Description
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.
DMSI Financial Timeline
Browse a chronological timeline of Dermisonics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
DMSI Stock Performance
Access detailed DMSI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.